267 related articles for article (PubMed ID: 27913621)
1. Identification of Hepatic Lysophosphatidylcholine Acyltransferase 3 as a Novel Target Gene Regulated by Peroxisome Proliferator-activated Receptor δ.
Singh AB; Liu J
J Biol Chem; 2017 Jan; 292(3):884-897. PubMed ID: 27913621
[TBL] [Abstract][Full Text] [Related]
2. A novel peroxisome proliferator response element modulates hepatic low-density lipoprotein receptor gene transcription in response to PPARδ activation.
Shende VR; Singh AB; Liu J
Biochem J; 2015 Dec; 472(3):275-86. PubMed ID: 26443862
[TBL] [Abstract][Full Text] [Related]
3. Identification and characterization of a major liver lysophosphatidylcholine acyltransferase.
Zhao Y; Chen YQ; Bonacci TM; Bredt DS; Li S; Bensch WR; Moller DE; Kowala M; Konrad RJ; Cao G
J Biol Chem; 2008 Mar; 283(13):8258-65. PubMed ID: 18195019
[TBL] [Abstract][Full Text] [Related]
4. Long chain acyl-CoA synthetase-3 is a molecular target for peroxisome proliferator-activated receptor delta in HepG2 hepatoma cells.
Cao A; Li H; Zhou Y; Wu M; Liu J
J Biol Chem; 2010 May; 285(22):16664-74. PubMed ID: 20308079
[TBL] [Abstract][Full Text] [Related]
5. Deficiency in lysophosphatidylcholine acyltransferase 3 reduces plasma levels of lipids by reducing lipid absorption in mice.
Li Z; Jiang H; Ding T; Lou C; Bui HH; Kuo MS; Jiang XC
Gastroenterology; 2015 Nov; 149(6):1519-29. PubMed ID: 26226572
[TBL] [Abstract][Full Text] [Related]
6. Lysophosphatidylcholine acyltransferase 3 knockdown-mediated liver lysophosphatidylcholine accumulation promotes very low density lipoprotein production by enhancing microsomal triglyceride transfer protein expression.
Li Z; Ding T; Pan X; Li Y; Li R; Sanders PE; Kuo MS; Hussain MM; Cao G; Jiang XC
J Biol Chem; 2012 Jun; 287(24):20122-31. PubMed ID: 22511767
[TBL] [Abstract][Full Text] [Related]
7. VLDL hydrolysis by hepatic lipase regulates PPARδ transcriptional responses.
Brown JD; Oligino E; Rader DJ; Saghatelian A; Plutzky J
PLoS One; 2011; 6(7):e21209. PubMed ID: 21750705
[TBL] [Abstract][Full Text] [Related]
8. Fatty acid remodeling by LPCAT3 enriches arachidonate in phospholipid membranes and regulates triglyceride transport.
Hashidate-Yoshida T; Harayama T; Hishikawa D; Morimoto R; Hamano F; Tokuoka SM; Eto M; Tamura-Nakano M; Yanobu-Takanashi R; Mukumoto Y; Kiyonari H; Okamura T; Kita Y; Shindou H; Shimizu T
Elife; 2015 Apr; 4():. PubMed ID: 25898003
[TBL] [Abstract][Full Text] [Related]
9. Liver x receptor regulates arachidonic acid distribution and eicosanoid release in human macrophages: a key role for lysophosphatidylcholine acyltransferase 3.
Ishibashi M; Varin A; Filomenko R; Lopez T; Athias A; Gambert P; Blache D; Thomas C; Gautier T; Lagrost L; Masson D
Arterioscler Thromb Vasc Biol; 2013 Jun; 33(6):1171-9. PubMed ID: 23580142
[TBL] [Abstract][Full Text] [Related]
10. Peroxisome proliferator-activated receptor-delta induces insulin-induced gene-1 and suppresses hepatic lipogenesis in obese diabetic mice.
Qin X; Xie X; Fan Y; Tian J; Guan Y; Wang X; Zhu Y; Wang N
Hepatology; 2008 Aug; 48(2):432-41. PubMed ID: 18627005
[TBL] [Abstract][Full Text] [Related]
11. Substrate preferences of a lysophosphatidylcholine acyltransferase highlight its role in phospholipid remodeling.
Kazachkov M; Chen Q; Wang L; Zou J
Lipids; 2008 Oct; 43(10):895-902. PubMed ID: 18781350
[TBL] [Abstract][Full Text] [Related]
12. Liver-specific overexpression of LPCAT3 reduces postprandial hyperglycemia and improves lipoprotein metabolic profile in mice.
Cash JG; Hui DY
Nutr Diabetes; 2016 Apr; 6(4):e206. PubMed ID: 27110687
[TBL] [Abstract][Full Text] [Related]
13. Dietary capsaicin prevents nonalcoholic fatty liver disease through transient receptor potential vanilloid 1-mediated peroxisome proliferator-activated receptor δ activation.
Li Q; Li L; Wang F; Chen J; Zhao Y; Wang P; Nilius B; Liu D; Zhu Z
Pflugers Arch; 2013 Sep; 465(9):1303-16. PubMed ID: 23605066
[TBL] [Abstract][Full Text] [Related]
14. Lpcat3-dependent production of arachidonoyl phospholipids is a key determinant of triglyceride secretion.
Rong X; Wang B; Dunham MM; Hedde PN; Wong JS; Gratton E; Young SG; Ford DA; Tontonoz P
Elife; 2015 Mar; 4():. PubMed ID: 25806685
[TBL] [Abstract][Full Text] [Related]
15. Porcine peroxisome proliferator-activated receptor delta mediates the lipolytic effects of dietary fish oil to reduce body fat deposition.
Yu YH; Wang PH; Cheng WT; Mersmann HJ; Wu SC; Ding ST
J Anim Sci; 2010 Jun; 88(6):2009-18. PubMed ID: 20190170
[TBL] [Abstract][Full Text] [Related]
16. Research progress, challenges and perspectives of phospholipids metabolism in the LXR‑LPCAT3 signaling pathway and its relation to NAFLD (Review).
Wang J; Li J; Fu Y; Zhu Y; Lin L; Li Y
Int J Mol Med; 2024 Apr; 53(4):. PubMed ID: 38362962
[TBL] [Abstract][Full Text] [Related]
17. Differential 3,5,3'-triiodothyronine-mediated regulation of uncoupling protein 3 transcription: role of Fatty acids.
de Lange P; Feola A; Ragni M; Senese R; Moreno M; Lombardi A; Silvestri E; Amat R; Villarroya F; Goglia F; Lanni A
Endocrinology; 2007 Aug; 148(8):4064-72. PubMed ID: 17478558
[TBL] [Abstract][Full Text] [Related]
18. Germ cell nuclear factor directly represses the transcription of peroxisome proliferator-activated receptor delta gene.
He C; Ding N; Kang J
Acta Biochim Biophys Sin (Shanghai); 2008 Mar; 40(3):253-60. PubMed ID: 18330480
[TBL] [Abstract][Full Text] [Related]
19. PPARdelta ligand L-165041 ameliorates Western diet-induced hepatic lipid accumulation and inflammation in LDLR-/- mice.
Lim HJ; Park JH; Lee S; Choi HE; Lee KS; Park HY
Eur J Pharmacol; 2009 Nov; 622(1-3):45-51. PubMed ID: 19766624
[TBL] [Abstract][Full Text] [Related]
20. PPARδ activation induces hepatic long-chain acyl-CoA synthetase 4 expression in vivo and in vitro.
Kan CF; Singh AB; Dong B; Shende VR; Liu J
Biochim Biophys Acta; 2015 May; 1851(5):577-87. PubMed ID: 25645621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
